chenodeoxycholic acid has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gwak, GY; Jang, JJ; Kim, W; Lee, HS; Lee, SH; Myung, SJ; Yang, JI; Yoon, JH | 1 |
| Biagioli, M; Carino, A; Fiorucci, S; Limongelli, V; Marchianò, S; Scarpelli, P; Zampella, A | 1 |
2 other study(ies) available for chenodeoxycholic acid and transforming growth factor beta
| Article | Year |
|---|---|
Bile acid-mediated thrombospondin-1 induction in hepatocytes leads to transforming growth factor-beta-dependent hepatic stellate cell activation.
Topics: Bile Acids and Salts; Cell Line, Transformed; Cell Line, Tumor; Chenodeoxycholic Acid; Coculture Techniques; Collagen Type I; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression; Hepatocytes; Humans; Immunoblotting; Liver; Phosphorylation; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad2 Protein; Thrombospondin 1; Transforming Growth Factor beta | 2007 |
Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
Topics: Animals; Chenodeoxycholic Acid; Cholanes; Gene Expression Regulation; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Male; Mice, Inbred C57BL; Mice, Knockout; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta | 2018 |